{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:11:05Z","timestamp":1793211065154,"version":"4.5.0"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,12,16]],"date-time":"2023-12-16T00:00:00Z","timestamp":1702684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,16]],"date-time":"2023-12-16T00:00:00Z","timestamp":1702684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hormones"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s42000-023-00515-w","type":"journal-article","created":{"date-parts":[[2023,12,16]],"date-time":"2023-12-16T08:01:27Z","timestamp":1702713687000},"page":"205-216","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Endocrinopathies in beta thalassemia: a narrative review"],"prefix":"10.1007","volume":"23","author":[{"given":"Theodora-Maria","family":"Venou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fani","family":"Barmpageorgopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melpomeni","family":"Peppa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efthimia","family":"Vlachaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,16]]},"reference":[{"key":"515_CR1","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.3390\/diagnostics12081921","volume":"12","author":"M Carsote","year":"2022","unstructured":"Carsote M, Vasiliu C, Trandafir AI et al (2022) New entity\u2014thalassemic endocrine disease: major beta-thalassemia and endocrine involvement. Diagnostics 12:1921. https:\/\/doi.org\/10.3390\/diagnostics12081921","journal-title":"Diagnostics"},{"key":"515_CR2","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.hoc.2017.11.006","volume":"32","author":"V Viprakasit","year":"2018","unstructured":"Viprakasit V, Ekwattanakit S (2018) Clinical classification, screening and diagnosis for thalassemia. Hematol Oncol Clin North Am 32:193\u2013211","journal-title":"Hematol Oncol Clin North Am"},{"key":"515_CR3","doi-asserted-by":"publisher","unstructured":"De Sanctis V, Soliman AT, Elsedfy H et al (2016) The ICET-A recommendations for the diagnosis and management of disturbances of glucose homeostasis in thalassemia major patients. Mediterr J Hematol Infect Dis 8. https:\/\/doi.org\/10.4084\/MJHID.2016.058","DOI":"10.4084\/MJHID.2016.058"},{"key":"515_CR4","doi-asserted-by":"publisher","first-page":"850","DOI":"10.2337\/diacare.24.5.850","volume":"24","author":"JPS Chern","year":"2001","unstructured":"Chern JPS, Lin K-H, Lu M-Y et al (2001) Abnormal glucose tolerance in transfusion-dependent-thalassemic patients. Diabetes Care 24:850\u2013854. https:\/\/doi.org\/10.2337\/diacare.24.5.850","journal-title":"Diabetes Care"},{"key":"515_CR5","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/pedi.12793","volume":"20","author":"MH El-Samahy","year":"2019","unstructured":"El-Samahy MH, Tantawy AA, Adly AA et al (2019) Evaluation of continuous glucose monitoring system for detection of alterations in glucose homeostasis in pediatric patients with \u03b2-thalassemia major. Pediatr Diabetes 20:65\u201372. https:\/\/doi.org\/10.1111\/pedi.12793","journal-title":"Pediatr Diabetes"},{"key":"515_CR6","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1080\/03630260902817131","volume":"33","author":"M Hafez","year":"2009","unstructured":"Hafez M, Youssry L, El-Hamed FA, Ibrahim A (2009) Abnormal glucose tolerance in \u03b2thalassemia: assessment of risk factors. Hemoglobin 33:101\u2013108. https:\/\/doi.org\/10.1080\/03630260902817131","journal-title":"Hemoglobin"},{"key":"515_CR7","doi-asserted-by":"publisher","first-page":"e2023006","DOI":"10.4084\/mjhid.2023.006","volume":"15","author":"V De Sanctis","year":"2023","unstructured":"De Sanctis V, Soliman A, Daar S et al (2023) Glucose homeostasis and assessment of b-cell function by 3-hour oral glucose tolerance test (OGTT) in patients with b-thalassemia major with serum ferritin below 1000ng\/dl: results from a single ICET-A Centre. Mediterr J Hematol Infect Dis 15:e2023006. https:\/\/doi.org\/10.4084\/mjhid.2023.006","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"515_CR8","doi-asserted-by":"publisher","unstructured":"He LN, Chen W, Yang Y et al (2019) Elevated prevalence of abnormal glucose metabolism and other endocrine disorders in patients with \u03b2 -thalassemia major: a meta-analysis. Biomed Res Int 2019 https:\/\/doi.org\/10.1155\/2019\/6573497","DOI":"10.1155\/2019\/6573497"},{"key":"515_CR9","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1111\/j.1365-2265.1995.tb02683.x","volume":"42","author":"V De Sanctis","year":"1995","unstructured":"De Sanctis V (1995) Multicentre study on prevalence of endocrine complications in thalassaemia major. Clin Endocrinol 42:581\u2013586. https:\/\/doi.org\/10.1111\/j.1365-2265.1995.tb02683.x","journal-title":"Clin Endocrinol"},{"key":"515_CR10","doi-asserted-by":"publisher","unstructured":"De Sanctis V, Soliman AT, Daar S et al (2023) Longitudinal study of ICET-A on glucose tolerance, insulin sensitivity and \u03b2-cell secretion in eleven \u03b2-thalassemia major patients with mild iron overload. Acta Biomedica 94. https:\/\/doi.org\/10.23750\/abm.v94i1.14000","DOI":"10.23750\/abm.v94i1.14000"},{"key":"515_CR11","doi-asserted-by":"publisher","unstructured":"Crafa A, Calogero AE, Cannarella R et al (2021) The burden of hormonal disorders: a worldwide overview with a particular look in Italy. Front Endocrinol (Lausanne) 12. https:\/\/doi.org\/10.3389\/fendo.2021.694325","DOI":"10.3389\/fendo.2021.694325"},{"key":"515_CR12","doi-asserted-by":"publisher","first-page":"152","DOI":"10.15386\/mpr-2053","volume":"95","author":"SZ Hussein","year":"2022","unstructured":"Hussein SZ (2022) Evaluation of thyroid hormones and ferritin level in patients with \u03b2-thalassemia. Med Pharm Rep 95:152\u2013157. https:\/\/doi.org\/10.15386\/mpr-2053","journal-title":"Med Pharm Rep"},{"key":"515_CR13","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1159\/000205032","volume":"84","author":"S Magro","year":"1990","unstructured":"Magro S, Puzzonia P, Consarino C et al (1990) Hypothyroidism in patients with thalassemia syndromes. ACTA Haematol 84:72\u201376. https:\/\/doi.org\/10.1159\/000205032","journal-title":"ACTA Haematol"},{"key":"515_CR14","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1515\/jpem.2006.19.12.1397","volume":"19","author":"A Filosa","year":"2006","unstructured":"Filosa A, Di Maio S, Aloj G et al (2006) Longitudinal study on thyroid function in patients with thalassemia major. J Pediatr Endocrinol Metab 19:1397\u20131404. https:\/\/doi.org\/10.1515\/jpem.2006.19.12.1397","journal-title":"J Pediatr Endocrinol Metab"},{"key":"515_CR15","doi-asserted-by":"publisher","unstructured":"Bazi A, Harati H, Khosravi-Bonjar A et al (2018) Hypothyroidism and hypoparathyroidism in thalassemia major patients: a study in Sistan and Baluchestan Province, Iran. Int J Endocrinol Metab 16. https:\/\/doi.org\/10.5812\/ijem.13228","DOI":"10.5812\/ijem.13228"},{"key":"515_CR16","doi-asserted-by":"publisher","first-page":"55","DOI":"10.23750\/abm.v89i1.5778","volume":"89","author":"S Haghpanah","year":"2018","unstructured":"Haghpanah S, Jelodari S, Karamifar H et al (2018) The frequency of hypothyroidism and its relationship with HCV positivity in patients with thalassemia major in Southern Iran. Acta Biomedica 89:55\u201360. https:\/\/doi.org\/10.23750\/abm.v89i1.5778","journal-title":"Acta Biomedica"},{"key":"515_CR17","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1097\/01.EPX.0000436490.10201.28","volume":"88","author":"ARA Abdel-Razek","year":"2013","unstructured":"Abdel-Razek ARA, Abdel-Salam A, El-Sonbaty MM, Youness ER (2013) Study of thyroid function in Egyptian children with \u03b2-thalassemia major and \u03b2-thalassemia intermedia. J Egypt Public Health Assoc 88:148\u2013152. https:\/\/doi.org\/10.1097\/01.EPX.0000436490.10201.28","journal-title":"J Egypt Public Health Assoc"},{"key":"515_CR18","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3329\/bmrcb.v35i2.2534","volume":"35","author":"G Gathwala","year":"2009","unstructured":"Gathwala G, Das K, Agrawal N (2009) Thyroid hormone profile in beta-thalassemia major children. Bangladesh Med Res Counc Bull 35:71\u201372. https:\/\/doi.org\/10.3329\/bmrcb.v35i2.2534","journal-title":"Bangladesh Med Res Counc Bull"},{"key":"515_CR19","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1089\/105072502753522383","volume":"12","author":"A Zervas","year":"2002","unstructured":"Zervas A, Katopodi A, Protonotariou A et al (2002) Assessment of thyroid function in two hundred patients with b-thalassemia major. Thyroid 12:151\u2013154. https:\/\/doi.org\/10.1089\/105072502753522383","journal-title":"Thyroid"},{"key":"515_CR20","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1097\/MPH.0000000000001489","volume":"41","author":"A Baghersalimi","year":"2019","unstructured":"Baghersalimi A, Rad AH, Koohmanaee S et al (2019) The cutoff of ferritin for evaluation of hypothyroidism in patients with thalassemia. J Pediatr Hematol Oncol 41:515\u2013518. https:\/\/doi.org\/10.1097\/MPH.0000000000001489","journal-title":"J Pediatr Hematol Oncol"},{"key":"515_CR21","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/j.1365-2265.1993.tb00973.x","volume":"38","author":"H Landau","year":"1993","unstructured":"Landau H, Goldfarbs A, Rachmilewitt EA et al (1993) Cross-sectional and longitudinal study of the pituitary-thyroid axis in patients with thalassaemia major. Clin Endocrinol (Oxf) 38:55\u201361. https:\/\/doi.org\/10.1111\/j.1365-2265.1993.tb00973.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"515_CR22","doi-asserted-by":"publisher","first-page":"435","DOI":"10.23750\/abm.v88i4.6837","volume":"88","author":"V De Sanctis","year":"2017","unstructured":"De Sanctis V, Soliman AT, Canatan D et al (2017) An ICET- a survey on hypoparathyroidism in patients with thalassaemia major and intermedia: a preliminary report. Acta Biomedica 88:435\u2013444. https:\/\/doi.org\/10.23750\/abm.v88i4.6837","journal-title":"Acta Biomedica"},{"key":"515_CR23","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1007\/s00774-005-0660-1","volume":"24","author":"NG Angelopoulos","year":"2006","unstructured":"Angelopoulos NG, Goula A, Rombopoulos G et al (2006) Hypoparathyroidism in transfusion-dependent patients with \u03b2-thalassemia. J Bone Miner Metab 24:138\u2013145. https:\/\/doi.org\/10.1007\/s00774-005-0660-1","journal-title":"J Bone Miner Metab"},{"key":"515_CR24","doi-asserted-by":"publisher","first-page":"324","DOI":"10.4274\/jcrpe.0020","volume":"10","author":"H Tangngam","year":"2018","unstructured":"Tangngam H, Mahachoklertwattana P, Poomthavorn P et al (2018) Under-recognized hypoparathyroidism in thalassemia. J Clin Res Pediatr Endocrinol 10:324\u2013330. https:\/\/doi.org\/10.4274\/jcrpe.0020","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"515_CR25","doi-asserted-by":"publisher","unstructured":"Origa R, Fiumana E, Gamberini MR et al (2005) Osteoporosis in \u03b2-thalassemia: clinical and genetic aspects. In: Annals of the New York Academy of Sciences. New York Academy of Sciences, 451\u2013456. https:\/\/doi.org\/10.1196\/annals.1345.051","DOI":"10.1196\/annals.1345.051"},{"key":"515_CR26","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1177\/0284185117730099","volume":"59","author":"M Bozda\u011f","year":"2018","unstructured":"Bozda\u011f M, Bayraktaro\u011flu S, Ayd\u0131nok Y, \u00c7all\u0131 MC (2018) MRI assessment of pituitary iron accumulation by using pituitary-R2 in \u03b2-thalassemia patients. Acta radiol 59:732\u2013739. https:\/\/doi.org\/10.1177\/0284185117730099","journal-title":"Acta radiol"},{"key":"515_CR27","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3810\/pgm.2014.09.2806","volume":"126","author":"A Albu","year":"2014","unstructured":"Albu A, Barbu CG, Antonie L et al (2014) Risk factors associated with hypogonadism in \u03b2-Thalassemia major patients: predictors for a frequent complication of a rare disease. Postgrad Med 126:121\u2013127. https:\/\/doi.org\/10.3810\/pgm.2014.09.2806","journal-title":"Postgrad Med"},{"key":"515_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF03348567","volume":"13","author":"R Balducci","year":"2014","unstructured":"Balducci R, Toscano V, Finocchi G et al (2014) Effect of hCG or hCG + treatments in young thalassemic patients with hypogonadotropic hypogonadism. J Endocrinol Invest 13:1\u20137. https:\/\/doi.org\/10.1007\/BF03348567","journal-title":"J Endocrinol Invest"},{"key":"515_CR29","doi-asserted-by":"publisher","unstructured":"De Sanctis V, Daar S, Soliman AT et al (2022) Screening for glucose dysregulation in \u03b2-thalassemia major (\u03b2-TM): An update of current evidences and personal experience. Acta Biomedica 93. https:\/\/doi.org\/10.23750\/abm.v93i1.12802","DOI":"10.23750\/abm.v93i1.12802"},{"key":"515_CR30","doi-asserted-by":"publisher","unstructured":"Farmakis D, Porter J, Taher A et al (2022) 2021 Thalassaemia international federation guidelines for the management of transfusion-dependent Thalassemia. Hemasphere 6. https:\/\/doi.org\/10.1097\/HS9.0000000000000732","DOI":"10.1097\/HS9.0000000000000732"},{"key":"515_CR31","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1111\/pedi.13260","volume":"23","author":"L Zhang","year":"2022","unstructured":"Zhang L, Meng Z, Jiang Z et al (2022) Indicators of glucose dysregulation and the relationship with iron overload in Chinese children with beta thalassemia major. Pediatr Diabetes 23:562\u2013568. https:\/\/doi.org\/10.1111\/pedi.13260","journal-title":"Pediatr Diabetes"},{"key":"515_CR32","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1007\/s00125-015-3599-3","volume":"58","author":"E English","year":"2015","unstructured":"English E, Idris I, Smith G et al (2015) The effect of anaemia and abnormalities of erythrocyte indices on HbA1c analysis: a systematic review. Diabetologia 58:1409\u20131421. https:\/\/doi.org\/10.1007\/s00125-015-3599-3","journal-title":"Diabetologia"},{"key":"515_CR33","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1055\/s-0042-111691","volume":"228","author":"K Warncke","year":"2016","unstructured":"Warncke K, Konrad K, Kohne E et al (2016) Diabetes in patients with \u03b2-thalassemia or other hemoglobinopathies - analysis from the DPV database. Klin Padiatr 228:307\u2013312. https:\/\/doi.org\/10.1055\/s-0042-111691","journal-title":"Klin Padiatr"},{"key":"515_CR34","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/ajh.22223","volume":"87","author":"LJ Noetzli","year":"2012","unstructured":"Noetzli LJ, Mittelman SD, Watanabe RM et al (2012) Pancreatic iron and glucose dysregulation in thalassemia major. Am J Hematol 87:155\u2013160. https:\/\/doi.org\/10.1002\/ajh.22223","journal-title":"Am J Hematol"},{"key":"515_CR35","doi-asserted-by":"publisher","unstructured":"Ricchi P, Meloni A, Pistoia L et al (2023) Longitudinal prospective comparison of pancreatic iron by magnetic resonance in thalassemia\u00a0patients transfusion-dependent since early childhood treated with combination deferiprone- desferrioxamine vs deferiprone or deferasirox monotherapy. Blood Transfus 485. https:\/\/doi.org\/10.2450\/BloodTransfus.485","DOI":"10.2450\/BloodTransfus.485"},{"key":"515_CR36","doi-asserted-by":"publisher","first-page":"2830","DOI":"10.2337\/dc20-0908","volume":"43","author":"A Pepe","year":"2020","unstructured":"Pepe A, Pistoia L, Gamberini MR et al (2020) The close link of pancreatic iron with glucose metabolism and with cardiac complications in thalassemia major: a large, multicenter observational study. Diabetes Care 43:2830\u20132839. https:\/\/doi.org\/10.2337\/dc20-0908","journal-title":"Diabetes Care"},{"key":"515_CR37","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1097\/MPH.0000000000000767","volume":"39","author":"M Hashemieh","year":"2017","unstructured":"Hashemieh M, Radfar M, Azarkeivan A et al (2017) T2* magnetic resonance imaging study of pancreatic iron overload and its relation with the diabetic state in thalassemic patients. J Pediatr Hematol Oncol 39:337\u2013340. https:\/\/doi.org\/10.1097\/MPH.0000000000000767","journal-title":"J Pediatr Hematol Oncol"},{"key":"515_CR38","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s00431-002-1121-7","volume":"162","author":"H Cario","year":"2003","unstructured":"Cario H, Holl RW, Debatin KMM, Kohne E (2003) Insulin sensitivity and \u03b2-cell secretion in thalassaemia major with secondary haemochromatosis: assessment by oral glucose tolerance test. Eur J Pediatr 162:139\u2013146. https:\/\/doi.org\/10.1007\/s00431-002-1121-7","journal-title":"Eur J Pediatr"},{"key":"515_CR39","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3109\/09553000903347880","volume":"33","author":"R Chatterjee","year":"2009","unstructured":"Chatterjee R, Bajoria R (2009) New concept in natural history and management of diabetes mellitus in thalassemia major diabetes and thalassaemia. Hemoglobin 33:127\u2013130. https:\/\/doi.org\/10.3109\/09553000903347880","journal-title":"Hemoglobin"},{"key":"515_CR40","first-page":"393","volume":"43","author":"J Suvarna","year":"2006","unstructured":"Suvarna J, Ingle H, Deshmukh CT (2006) Insulin resistance and beta cell function in chronically transfused patients of thalassemia major. Indian Pediatr 43:393\u2013400","journal-title":"Indian Pediatr"},{"key":"515_CR41","doi-asserted-by":"publisher","first-page":"67","DOI":"10.2147\/jbm.s390666","volume":"14","author":"AS Ibrahim","year":"2023","unstructured":"Ibrahim AS, Abd El-Fatah AH, Abd El-Halim AF, Mohamed FF (2023) Serum ferritin levels and other associated parameters with diabetes mellitus in adult patients suffering from beta thalassemia major. J Blood Med 14:67\u201381. https:\/\/doi.org\/10.2147\/jbm.s390666","journal-title":"J Blood Med"},{"key":"515_CR42","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/ejh.12121","volume":"91","author":"M Casale","year":"2013","unstructured":"Casale M, Cinque P, Ricchi P et al (2013) Effect of splenectomy on iron balance in patients with \u03b2-thalassemia major: a long-term follow-up. Eur J Haematol 91:69\u201373. https:\/\/doi.org\/10.1111\/ejh.12121","journal-title":"Eur J Haematol"},{"key":"515_CR43","doi-asserted-by":"publisher","unstructured":"Meloni A, Pistoia L, Gamberini MR et al (2021) The link of pancreatic iron with glucose metabolism and cardiac iron in thalassemia intermedia: a large, multicenter observational study. J Clin Med 10. https:\/\/doi.org\/10.3390\/jcm10235561","DOI":"10.3390\/jcm10235561"},{"key":"515_CR44","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/ajh.25009","volume":"93","author":"VM Pinto","year":"2018","unstructured":"Pinto VM, Bacigalupo L, Gianesin B et al (2018) Lack of correlation between heart, liver and pancreas MRI-R2*: Results from long-term follow-up in a cohort of adult \u03b2-thalassemia major patients. Am J Hematol 93:79\u201382. https:\/\/doi.org\/10.1002\/ajh.25009","journal-title":"Am J Hematol"},{"key":"515_CR45","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1111\/j.1365-2141.2006.06203.x","volume":"134","author":"K Farmaki","year":"2006","unstructured":"Farmaki K, Angelopoulos N, Anagnostopoulos G et al (2006) Effect of enhanced iron chelation therapy on glucose metabolism in patients with \u03b2-thalassaemia major. Br J Haematol 134:438\u2013444. https:\/\/doi.org\/10.1111\/j.1365-2141.2006.06203.x","journal-title":"Br J Haematol"},{"key":"515_CR46","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1097\/00042737-199909000-00014","volume":"11","author":"C Labropoulou-Karatza","year":"1999","unstructured":"Labropoulou-Karatza C, Goritsas C, Fragopanagou H et al (1999) High prevalence of diabetes mellitus among adult \u03b2-thalassemic patients with chronic hepatitis C. Eur J Gastroenterol Hepatol 11:1033\u20131036. https:\/\/doi.org\/10.1097\/00042737-199909000-00014","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"515_CR47","doi-asserted-by":"publisher","unstructured":"De Sanctis V, Soliman A, Daar S et al (2022) Insulin-like growth factor-1 (IGF-1) and glucose dysregulation in young adult patients with \u03b2-thalassemia major: causality or potential link? Acta Biomedica 93. https:\/\/doi.org\/10.23750\/abm.v93i6.13288","DOI":"10.23750\/abm.v93i6.13288"},{"key":"515_CR48","doi-asserted-by":"publisher","unstructured":"de Sanctis V, Soliman AT, Daar S et al (2021) Long-term follow-up of \u03b2-transfusion-dependent thalassemia (TDT) normoglycemic patients with reduced insulin secretion to oral glucose tolerance test (OGTT): A pilot study. Mediterr J Hematol Infect Dis 13:. https:\/\/doi.org\/10.4084\/MJHID.2021.021","DOI":"10.4084\/MJHID.2021.021"},{"key":"515_CR49","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1111\/j.1365-2141.2006.06296.x","volume":"135","author":"A Christoforidis","year":"2006","unstructured":"Christoforidis A, Perifanis V, Athanassiou-Metaxa M (2006) Combined chelation therapy improves glucose metabolism in patients with \u03b2-thalassaemia major. Br J Haematol 135:271\u2013272. https:\/\/doi.org\/10.1111\/j.1365-2141.2006.06296.x","journal-title":"Br J Haematol"},{"key":"515_CR50","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1111\/j.1365-2141.2009.07970.x","volume":"148","author":"K Farmaki","year":"2010","unstructured":"Farmaki K, Tzoumari I, Pappa C et al (2010) Normalisation of total body iron load with very intensive combined chelation reverses cardiac and endocrine complications of thalassaemia major. Br J Haematol 148:466\u2013475. https:\/\/doi.org\/10.1111\/j.1365-2141.2009.07970.x","journal-title":"Br J Haematol"},{"key":"515_CR51","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1586\/17474086.2016.1136209","volume":"9","author":"V De Sanctis","year":"2016","unstructured":"De Sanctis V, Soliman AT, Elsedfy H et al (2016) Diabetes and glucose metabolism in thalassemia major: an update. Expert Rev Hematol 9:401\u2013408. https:\/\/doi.org\/10.1586\/17474086.2016.1136209","journal-title":"Expert Rev Hematol"},{"key":"515_CR52","doi-asserted-by":"publisher","unstructured":"de Sanctis V, Soliman A, Tzoulis P et al (2022) The use of oral glucose-lowering agents (GLAs) in \u03b2-thalassemia patients with diabetes: Preliminary data from a retrospective study of ICET-A Network. Acta Biomedica 93. https:\/\/doi.org\/10.23750\/abm.v93i2.12056","DOI":"10.23750\/abm.v93i2.12056"},{"key":"515_CR53","doi-asserted-by":"publisher","unstructured":"Stef\u00e1nsson B V., Heerspink HJL, Wheeler DC et al (2020) Correction of anemia by dapagliflozin in patients with type 2 diabetes. J Diabetes Complicat 34. https:\/\/doi.org\/10.1016\/j.jdiacomp.2020.107729","DOI":"10.1016\/j.jdiacomp.2020.107729"},{"key":"515_CR54","doi-asserted-by":"publisher","first-page":"119","DOI":"10.23750\/abm.v88i1.6048","volume":"88","author":"AT Soliman","year":"2017","unstructured":"Soliman AT, De Sanctis V, Yassin M et al (2017) Chronic anemia and thyroid function. Acta Biomedica 88:119\u2013127. https:\/\/doi.org\/10.23750\/abm.v88i1.6048","journal-title":"Acta Biomedica"},{"key":"515_CR55","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1136\/adc.58.2.120","volume":"58","author":"AR Sabato","year":"1983","unstructured":"Sabato AR, De Sanctis V, Atti G et al (1983) Primary hypothyroidism and the low T3 syndrome in thalassaemia major. Arch Dis Child 58:120\u2013127. https:\/\/doi.org\/10.1136\/adc.58.2.120","journal-title":"Arch Dis Child"},{"key":"515_CR56","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1182\/blood","volume":"115","author":"AT Taher","year":"2010","unstructured":"Taher AT, Musallam KM, Karimi M et al (2010) Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE study. Blood 115:1886\u20131892. https:\/\/doi.org\/10.1182\/blood","journal-title":"Blood"},{"key":"515_CR57","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1530\/EJE-13-0627","volume":"169","author":"V Chirico","year":"2013","unstructured":"Chirico V, Antonio L, Vincenzo S et al (2013) Thyroid dysfunction in thalassaemic patients: ferritin as a prognostic marker and combined iron chelators as an ideal therapy. Eur J Endocrinol 169:785\u2013793. https:\/\/doi.org\/10.1530\/EJE-13-0627","journal-title":"Eur J Endocrinol"},{"key":"515_CR58","doi-asserted-by":"publisher","first-page":"17","DOI":"10.2165\/11598070-000000000-00000","volume":"72","author":"D Khandelwal","year":"2012","unstructured":"Khandelwal D, Tandon N (2012) Overt and subclinical hypothyroidism who to treat and how. Drugs 72:17\u201333. https:\/\/doi.org\/10.2165\/11598070-000000000-00000","journal-title":"Drugs"},{"key":"515_CR59","doi-asserted-by":"publisher","unstructured":"Saki F, Salehifar A, Kassaee SR, Omrani GR (2020) Association of vitamin D and FGF23 with serum ferritin in hypoparathyroid thalassemia: a case control study. BMC Nephrol 21. https:\/\/doi.org\/10.1186\/s12882-020-02101-3","DOI":"10.1186\/s12882-020-02101-3"},{"key":"515_CR60","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1530\/eje.1.02316","volume":"156","author":"L Even","year":"2007","unstructured":"Even L, Bader T, Hochberg Z (2007) Nocturnal calcium, phosphorus and parathyroid hormone in the diagnosis of concealed and subclinical hypoparathyroidism. Eur J Endocrinol 156:113\u2013116. https:\/\/doi.org\/10.1530\/eje.1.02316","journal-title":"Eur J Endocrinol"},{"key":"515_CR61","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1067\/mpd.2001.112654","volume":"138","author":"DI Zafeiriou","year":"2001","unstructured":"Zafeiriou DI, Athanasiou M, Katzos G et al (2001) Hypoparathyroidism and intracranial calcifications in \u03b2-thalassemia. J Pediatr 138:411. https:\/\/doi.org\/10.1067\/mpd.2001.112654","journal-title":"J Pediatr"},{"key":"515_CR62","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.ejrad.2008.02.003","volume":"70","author":"M Karimi","year":"2009","unstructured":"Karimi M, Rasekhi AR, Rasekh M et al (2009) Hypoparathyroidism and intracerebral calcification in patients with beta-thalassemia major. Eur J Radiol 70:481\u2013484. https:\/\/doi.org\/10.1016\/j.ejrad.2008.02.003","journal-title":"Eur J Radiol"},{"key":"515_CR63","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1080\/10245330701448503","volume":"12","author":"N Abdelrazik","year":"2007","unstructured":"Abdelrazik N, Ghanem H (2007) Failure of puberty in Egyptian beta thalassemic patients: experience in north east region - Dakahlia province. Hematology 12:449\u2013456. https:\/\/doi.org\/10.1080\/10245330701448503","journal-title":"Hematology"},{"key":"515_CR64","doi-asserted-by":"publisher","first-page":"6","DOI":"10.23750\/abm.v89i2","volume":"89","author":"V De Sanctis","year":"2018","unstructured":"De Sanctis V, Soliman AT, Yassin MA et al (2018) Hypogonadism in male thalassemia major patients: pathophysiology, diagnosis and treatment. Acta Biomed 89:6\u201315. https:\/\/doi.org\/10.23750\/abm.v89i2","journal-title":"Acta Biomed"},{"key":"515_CR65","doi-asserted-by":"publisher","first-page":"228","DOI":"10.23750\/abm.v90i2.8477","volume":"90","author":"V de Sanctis","year":"2019","unstructured":"de Sanctis V, Soliman AT, Daar S, di Maio S (2019) Adverse events during testosterone replacement therapy in 95 young hypogonadal thalassemic men. Acta Biomedica 90:228\u2013232. https:\/\/doi.org\/10.23750\/abm.v90i2.8477","journal-title":"Acta Biomedica"},{"key":"515_CR66","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.ijgo.2005.03.024","volume":"90","author":"HS Al-Rimawi","year":"2005","unstructured":"Al-Rimawi HS, Jallad MF, Amarin ZO, Obeidat BR (2005) Hypothalamic-pituitary-gonadal function in adolescent females with beta-thalassemia major. Int J Gynecol Obstet 90:44\u201347. https:\/\/doi.org\/10.1016\/j.ijgo.2005.03.024","journal-title":"Int J Gynecol Obstet"},{"key":"515_CR67","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s13312-021-2258-7","volume":"58","author":"P Singh","year":"2021","unstructured":"Singh P, Samaddar S, Parakh N et al (2021) Pubertal development and its determinants in adolescents with transfusion-dependent thalassemia. Indian Pediatr 58:635\u2013638","journal-title":"Indian Pediatr"},{"key":"515_CR68","doi-asserted-by":"publisher","unstructured":"Arab-Zozani M, Kheyrandish S, Rastgar A, Miri-Moghaddam E (2021) A systematic review and meta-analysis of stature growth complications in \u03b2-thalassemia major patients. Ann Glob Health 87. https:\/\/doi.org\/10.5334\/aogh.3184","DOI":"10.5334\/aogh.3184"},{"key":"515_CR69","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.15572","author":"Z Shahid","year":"2021","unstructured":"Shahid Z, Hassan S, Ghazanfar S et al (2021) investigating the role of ferritin in determining sexual underdevelopment in beta-thalassemia major patients: a cross-sectional analysis from Pakistan. Cureus. https:\/\/doi.org\/10.7759\/cureus.15572","journal-title":"Cureus"},{"key":"515_CR70","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1136\/adc.71.2.128","volume":"71","author":"RG Grundy","year":"1994","unstructured":"Grundy RG, Woods KA, Savage MO, Evans JP (1994) Relationship of endocrinopathy to iron chelation status in young patients with thalassaemia major. Arch Dis Child 71:128\u201332. https:\/\/doi.org\/10.1136\/adc.71.2.128","journal-title":"Arch Dis Child"},{"key":"515_CR71","doi-asserted-by":"publisher","first-page":"158","DOI":"10.23750\/abm.v90i1.8143","volume":"90","author":"V De Sanctis","year":"2019","unstructured":"De Sanctis V, Soliman AT, Daar S et al (2019) The experience of a tertiary unit on the clinical phenotype and management of hypogonadism in female adolescents and young adults with transfusion dependent thalassemia. Acta Biomedica 90:158\u2013167. https:\/\/doi.org\/10.23750\/abm.v90i1.8143","journal-title":"Acta Biomedica"},{"key":"515_CR72","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1056\/NEJM199009133231104","volume":"323","author":"B-W Naomi","year":"1990","unstructured":"Naomi B-W, Olivieri NF, Beverley T et al (1990) Effect of age at the start of iron chelation therapy on gonadal function in \u03b2- thalassemia major. N Engl J Med 323:713\u2013719. https:\/\/doi.org\/10.1056\/NEJM199009133231104","journal-title":"N Engl J Med"},{"key":"515_CR73","doi-asserted-by":"publisher","first-page":"149","DOI":"10.7123\/01.EJH.0000434285.33634.83","volume":"38","author":"M Elalfy","year":"2013","unstructured":"Elalfy M, Ragab E, Abdel-Aziz E et al (2013) Deferiprone and desferrioxamine combined chelation could improve puberty of adolescent males with b-thalassemia major with preserved pituitary and testicular function. Egypt J Haematol 38:149\u2013154. https:\/\/doi.org\/10.7123\/01.EJH.0000434285.33634.83","journal-title":"Egypt J Haematol"},{"key":"515_CR74","doi-asserted-by":"publisher","first-page":"33","DOI":"10.23750\/abm.v89i2","volume":"89","author":"MA Yassin","year":"2018","unstructured":"Yassin MA, Soliman AT, De Sanctis V et al (2018) Statural growth and prevalence of endocrinopathies in relation to liver iron content (LIC) in adult patients with beta thalassemia major (BTM) and sickle cell disease (SCD). Acta Biomed 89:33\u201340. https:\/\/doi.org\/10.23750\/abm.v89i2","journal-title":"Acta Biomed"},{"key":"515_CR75","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1007\/s002340100634","volume":"43","author":"M Argyropoulou","year":"2001","unstructured":"Argyropoulou M, Kiortsis D, Metafratzi Z et al (2001) Pituitary gland height evaluated by MR in patients with \u03b2-thalassemia major: a marker of pituitary gland function. Neuroradiology 43:1056\u20131058. https:\/\/doi.org\/10.1007\/s002340100634","journal-title":"Neuroradiology"},{"key":"515_CR76","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1080\/17474086.2017.1398080","volume":"10","author":"V De Sanctis","year":"2017","unstructured":"De Sanctis V, Soliman AT, Elsedfy H et al (2017) Gonadal dysfunction in adult male patients with thalassemia major: an update for clinicians caring for thalassemia. Expert Rev Hematol 10:1095\u20131106. https:\/\/doi.org\/10.1080\/17474086.2017.1398080","journal-title":"Expert Rev Hematol"},{"key":"515_CR77","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1136\/jcp.41.2.133","volume":"41","author":"V De Sanctis","year":"1988","unstructured":"De Sanctis V, Vullo C, Katz M et al (1988) Gonadal function in patients with \u03b2 thalassaemia major. J Clin Pathol 41:133\u2013137. https:\/\/doi.org\/10.1136\/jcp.41.2.133","journal-title":"J Clin Pathol"},{"key":"515_CR78","doi-asserted-by":"publisher","first-page":"110","DOI":"10.4274\/jcrpe.galenos.2018.2018.0074","volume":"11","author":"A Gaudio","year":"2019","unstructured":"Gaudio A, Morabito N, Catalano A et al (2019) Pathogenesis of thalassemia major-associated osteoporosis: a review with insights from clinical experience. JCRPE J Clin Res Pediatr Endocrinol 11:110\u2013117. https:\/\/doi.org\/10.4274\/jcrpe.galenos.2018.2018.0074","journal-title":"JCRPE J Clin Res Pediatr Endocrinol"},{"key":"515_CR79","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1097\/MPH.0000000000000199","volume":"37","author":"KE Huang","year":"2015","unstructured":"Huang KE, Mittelman SD, Coates TD et al (2015) A significant proportion of thalassemia major patients have adrenal insufficiency detectable on provocative testing. J Pediatr Hematol Oncol 37:54\u201359. https:\/\/doi.org\/10.1097\/MPH.0000000000000199","journal-title":"J Pediatr Hematol Oncol"},{"key":"515_CR80","doi-asserted-by":"publisher","first-page":"4609","DOI":"10.1210\/jc.2010-0205","volume":"95","author":"P Poomthavorn","year":"2010","unstructured":"Poomthavorn P, Isaradisaikul B, Chuansumrit A et al (2010) High prevalence of \u201cbiochemical\u201d adrenal insufficiency in thalassemics: is it a matter of different testings or decreased cortisol binding globulin? J Clin Endocrinol Metab 95:4609\u20134615. https:\/\/doi.org\/10.1210\/jc.2010-0205","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Hormones"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-023-00515-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s42000-023-00515-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-023-00515-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T22:16:42Z","timestamp":1719958602000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s42000-023-00515-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,16]]},"references-count":80,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["515"],"URL":"https:\/\/doi.org\/10.1007\/s42000-023-00515-w","relation":{},"ISSN":["1109-3099","2520-8721"],"issn-type":[{"value":"1109-3099","type":"print"},{"value":"2520-8721","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,16]]},"assertion":[{"value":"8 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}